logo

MENS

Jyong Biotech·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
5.54 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Is MENS a Good Buy Right Now?
  • Based on a composite score of 5.54/10, we rate MENS as a Netural. Our analysis breaks down into 2.19/10 for Fundamentals, 6.77/10 for Technicals, and 7.65/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is MENS undervalued or overvalued?
Technical Analysis of MENS?
What is the analyst consensus for MENS?